nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A2—Gemfibrozil—coronary artery disease	0.066	0.184	CbGbCtD
Dexmedetomidine—CYP1A2—Clopidogrel—coronary artery disease	0.0572	0.16	CbGbCtD
Dexmedetomidine—CYP2D6—Niacin—coronary artery disease	0.0357	0.0998	CbGbCtD
Dexmedetomidine—CYP2D6—Timolol—coronary artery disease	0.0332	0.0928	CbGbCtD
Dexmedetomidine—CYP2D6—Captopril—coronary artery disease	0.0292	0.0817	CbGbCtD
Dexmedetomidine—CYP2D6—Simvastatin—coronary artery disease	0.0282	0.0789	CbGbCtD
Dexmedetomidine—CYP1A2—Losartan—coronary artery disease	0.0279	0.078	CbGbCtD
Dexmedetomidine—CYP2D6—Pravastatin—coronary artery disease	0.0276	0.0772	CbGbCtD
Dexmedetomidine—CYP2D6—Lovastatin—coronary artery disease	0.0276	0.0772	CbGbCtD
Dexmedetomidine—CYP2D6—Atorvastatin—coronary artery disease	0.0252	0.0703	CbGbCtD
Dexmedetomidine—Somnolence—Captopril—coronary artery disease	0.000216	0.000546	CcSEcCtD
Dexmedetomidine—Tachycardia—Losartan—coronary artery disease	0.000216	0.000546	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Pravastatin—coronary artery disease	0.000216	0.000546	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000216	0.000546	CcSEcCtD
Dexmedetomidine—Body temperature increased—Olmesartan—coronary artery disease	0.000216	0.000544	CcSEcCtD
Dexmedetomidine—Abdominal pain—Olmesartan—coronary artery disease	0.000216	0.000544	CcSEcCtD
Dexmedetomidine—Hypotension—Furosemide—coronary artery disease	0.000215	0.000542	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000215	0.000542	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Losartan—coronary artery disease	0.000214	0.000541	CcSEcCtD
Dexmedetomidine—Pain—Telmisartan—coronary artery disease	0.000214	0.00054	CcSEcCtD
Dexmedetomidine—Constipation—Telmisartan—coronary artery disease	0.000214	0.00054	CcSEcCtD
Dexmedetomidine—Agitation—Ramipril—coronary artery disease	0.000214	0.00054	CcSEcCtD
Dexmedetomidine—Diarrhoea—Clopidogrel—coronary artery disease	0.000214	0.00054	CcSEcCtD
Dexmedetomidine—Mental disorder—Lisinopril—coronary artery disease	0.000213	0.000537	CcSEcCtD
Dexmedetomidine—Diarrhoea—Lovastatin—coronary artery disease	0.000212	0.000536	CcSEcCtD
Dexmedetomidine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000211	0.000533	CcSEcCtD
Dexmedetomidine—Malnutrition—Lisinopril—coronary artery disease	0.000211	0.000533	CcSEcCtD
Dexmedetomidine—Dyspnoea—Perindopril—coronary artery disease	0.000211	0.000532	CcSEcCtD
Dexmedetomidine—Body temperature increased—Niacin—coronary artery disease	0.000211	0.000532	CcSEcCtD
Dexmedetomidine—Abdominal pain—Niacin—coronary artery disease	0.000211	0.000532	CcSEcCtD
Dexmedetomidine—Dizziness—Fenofibrate—coronary artery disease	0.00021	0.000531	CcSEcCtD
Dexmedetomidine—Somnolence—Perindopril—coronary artery disease	0.00021	0.00053	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Trandolapril—coronary artery disease	0.00021	0.00053	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Enalapril—coronary artery disease	0.000209	0.000528	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000208	0.000526	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ezetimibe—coronary artery disease	0.000208	0.000526	CcSEcCtD
Dexmedetomidine—Constipation—Captopril—coronary artery disease	0.000208	0.000526	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000208	0.000524	CcSEcCtD
Dexmedetomidine—Abdominal pain—Pravastatin—coronary artery disease	0.000207	0.000524	CcSEcCtD
Dexmedetomidine—Body temperature increased—Pravastatin—coronary artery disease	0.000207	0.000524	CcSEcCtD
Dexmedetomidine—Hypotension—Losartan—coronary artery disease	0.000207	0.000523	CcSEcCtD
Dexmedetomidine—Dizziness—Clopidogrel—coronary artery disease	0.000207	0.000522	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Telmisartan—coronary artery disease	0.000206	0.000521	CcSEcCtD
Dexmedetomidine—Dizziness—Lovastatin—coronary artery disease	0.000205	0.000518	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000205	0.000517	CcSEcCtD
Dexmedetomidine—Somnolence—Furosemide—coronary artery disease	0.000204	0.000516	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000204	0.000515	CcSEcCtD
Dexmedetomidine—Diarrhoea—Eplerenone—coronary artery disease	0.000204	0.000515	CcSEcCtD
Dexmedetomidine—Pain—Perindopril—coronary artery disease	0.000202	0.00051	CcSEcCtD
Dexmedetomidine—Constipation—Perindopril—coronary artery disease	0.000202	0.00051	CcSEcCtD
Dexmedetomidine—Vomiting—Fenofibrate—coronary artery disease	0.000202	0.00051	CcSEcCtD
Dexmedetomidine—Convulsion—Ramipril—coronary artery disease	0.000202	0.000509	CcSEcCtD
Dexmedetomidine—Abdominal pain—Trandolapril—coronary artery disease	0.000201	0.000509	CcSEcCtD
Dexmedetomidine—Body temperature increased—Trandolapril—coronary artery disease	0.000201	0.000509	CcSEcCtD
Dexmedetomidine—Dizziness—Ezetimibe—coronary artery disease	0.000201	0.000508	CcSEcCtD
Dexmedetomidine—Abdominal pain—Enalapril—coronary artery disease	0.000201	0.000507	CcSEcCtD
Dexmedetomidine—Body temperature increased—Enalapril—coronary artery disease	0.000201	0.000507	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Captopril—coronary artery disease	0.000201	0.000506	CcSEcCtD
Dexmedetomidine—Rash—Fenofibrate—coronary artery disease	0.0002	0.000506	CcSEcCtD
Dexmedetomidine—Dermatitis—Fenofibrate—coronary artery disease	0.0002	0.000505	CcSEcCtD
Dexmedetomidine—Headache—Fenofibrate—coronary artery disease	0.000199	0.000503	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Captopril—coronary artery disease	0.000199	0.000503	CcSEcCtD
Dexmedetomidine—Vomiting—Clopidogrel—coronary artery disease	0.000199	0.000501	CcSEcCtD
Dexmedetomidine—Diarrhoea—Simvastatin—coronary artery disease	0.000199	0.000501	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000198	0.000501	CcSEcCtD
Dexmedetomidine—Abdominal pain—Telmisartan—coronary artery disease	0.000198	0.0005	CcSEcCtD
Dexmedetomidine—Body temperature increased—Telmisartan—coronary artery disease	0.000198	0.0005	CcSEcCtD
Dexmedetomidine—Dyspnoea—Losartan—coronary artery disease	0.000198	0.000499	CcSEcCtD
Dexmedetomidine—Anxiety—Ramipril—coronary artery disease	0.000198	0.000499	CcSEcCtD
Dexmedetomidine—Vomiting—Lovastatin—coronary artery disease	0.000197	0.000498	CcSEcCtD
Dexmedetomidine—Somnolence—Losartan—coronary artery disease	0.000197	0.000498	CcSEcCtD
Dexmedetomidine—Dizziness—Eplerenone—coronary artery disease	0.000197	0.000497	CcSEcCtD
Dexmedetomidine—Rash—Clopidogrel—coronary artery disease	0.000197	0.000497	CcSEcCtD
Dexmedetomidine—Dermatitis—Clopidogrel—coronary artery disease	0.000197	0.000497	CcSEcCtD
Dexmedetomidine—Hypertension—Timolol—coronary artery disease	0.000197	0.000496	CcSEcCtD
Dexmedetomidine—Pain—Furosemide—coronary artery disease	0.000196	0.000496	CcSEcCtD
Dexmedetomidine—Constipation—Furosemide—coronary artery disease	0.000196	0.000496	CcSEcCtD
Dexmedetomidine—Headache—Clopidogrel—coronary artery disease	0.000196	0.000494	CcSEcCtD
Dexmedetomidine—Rash—Lovastatin—coronary artery disease	0.000196	0.000494	CcSEcCtD
Dexmedetomidine—Dermatitis—Lovastatin—coronary artery disease	0.000195	0.000494	CcSEcCtD
Dexmedetomidine—Anaemia—Lisinopril—coronary artery disease	0.000195	0.000493	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Perindopril—coronary artery disease	0.000195	0.000492	CcSEcCtD
Dexmedetomidine—Headache—Lovastatin—coronary artery disease	0.000194	0.000491	CcSEcCtD
Dexmedetomidine—Dry mouth—Ramipril—coronary artery disease	0.000194	0.00049	CcSEcCtD
Dexmedetomidine—Vomiting—Ezetimibe—coronary artery disease	0.000193	0.000489	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000193	0.000488	CcSEcCtD
Dexmedetomidine—Anxiety—Timolol—coronary artery disease	0.000193	0.000488	CcSEcCtD
Dexmedetomidine—Abdominal pain—Captopril—coronary artery disease	0.000192	0.000486	CcSEcCtD
Dexmedetomidine—Body temperature increased—Captopril—coronary artery disease	0.000192	0.000486	CcSEcCtD
Dexmedetomidine—Dizziness—Simvastatin—coronary artery disease	0.000192	0.000485	CcSEcCtD
Dexmedetomidine—Rash—Ezetimibe—coronary artery disease	0.000192	0.000484	CcSEcCtD
Dexmedetomidine—Dermatitis—Ezetimibe—coronary artery disease	0.000192	0.000484	CcSEcCtD
Dexmedetomidine—Confusional state—Ramipril—coronary artery disease	0.000192	0.000484	CcSEcCtD
Dexmedetomidine—Headache—Ezetimibe—coronary artery disease	0.000191	0.000481	CcSEcCtD
Dexmedetomidine—Dry mouth—Timolol—coronary artery disease	0.00019	0.000479	CcSEcCtD
Dexmedetomidine—Pain—Losartan—coronary artery disease	0.00019	0.000479	CcSEcCtD
Dexmedetomidine—Constipation—Losartan—coronary artery disease	0.00019	0.000479	CcSEcCtD
Dexmedetomidine—Vomiting—Eplerenone—coronary artery disease	0.000189	0.000478	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Furosemide—coronary artery disease	0.000189	0.000478	CcSEcCtD
Dexmedetomidine—Nausea—Fenofibrate—coronary artery disease	0.000189	0.000477	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000188	0.000474	CcSEcCtD
Dexmedetomidine—Rash—Eplerenone—coronary artery disease	0.000188	0.000474	CcSEcCtD
Dexmedetomidine—Dermatitis—Eplerenone—coronary artery disease	0.000188	0.000474	CcSEcCtD
Dexmedetomidine—Diarrhoea—Valsartan—coronary artery disease	0.000188	0.000473	CcSEcCtD
Dexmedetomidine—Confusional state—Timolol—coronary artery disease	0.000187	0.000473	CcSEcCtD
Dexmedetomidine—Abdominal pain—Perindopril—coronary artery disease	0.000187	0.000472	CcSEcCtD
Dexmedetomidine—Body temperature increased—Perindopril—coronary artery disease	0.000187	0.000472	CcSEcCtD
Dexmedetomidine—Diarrhoea—Olmesartan—coronary artery disease	0.000187	0.000471	CcSEcCtD
Dexmedetomidine—Headache—Eplerenone—coronary artery disease	0.000187	0.000471	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Ramipril—coronary artery disease	0.000186	0.00047	CcSEcCtD
Dexmedetomidine—Nausea—Clopidogrel—coronary artery disease	0.000186	0.000468	CcSEcCtD
Dexmedetomidine—Tachycardia—Ramipril—coronary artery disease	0.000185	0.000468	CcSEcCtD
Dexmedetomidine—Infection—Timolol—coronary artery disease	0.000185	0.000466	CcSEcCtD
Dexmedetomidine—Vomiting—Simvastatin—coronary artery disease	0.000185	0.000466	CcSEcCtD
Dexmedetomidine—Nausea—Lovastatin—coronary artery disease	0.000184	0.000465	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Ramipril—coronary artery disease	0.000184	0.000464	CcSEcCtD
Dexmedetomidine—Rash—Simvastatin—coronary artery disease	0.000183	0.000462	CcSEcCtD
Dexmedetomidine—Dermatitis—Simvastatin—coronary artery disease	0.000183	0.000462	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Losartan—coronary artery disease	0.000183	0.000461	CcSEcCtD
Dexmedetomidine—Diarrhoea—Niacin—coronary artery disease	0.000182	0.00046	CcSEcCtD
Dexmedetomidine—Headache—Simvastatin—coronary artery disease	0.000182	0.000459	CcSEcCtD
Dexmedetomidine—Abdominal pain—Furosemide—coronary artery disease	0.000182	0.000459	CcSEcCtD
Dexmedetomidine—Body temperature increased—Furosemide—coronary artery disease	0.000182	0.000459	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Losartan—coronary artery disease	0.000181	0.000458	CcSEcCtD
Dexmedetomidine—Dizziness—Valsartan—coronary artery disease	0.000181	0.000458	CcSEcCtD
Dexmedetomidine—Nausea—Ezetimibe—coronary artery disease	0.000181	0.000456	CcSEcCtD
Dexmedetomidine—Dizziness—Olmesartan—coronary artery disease	0.00018	0.000455	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Timolol—coronary artery disease	0.00018	0.000454	CcSEcCtD
Dexmedetomidine—Diarrhoea—Pravastatin—coronary artery disease	0.00018	0.000453	CcSEcCtD
Dexmedetomidine—Anxiety—Lisinopril—coronary artery disease	0.000179	0.000452	CcSEcCtD
Dexmedetomidine—Hypotension—Ramipril—coronary artery disease	0.000178	0.000448	CcSEcCtD
Dexmedetomidine—Nausea—Eplerenone—coronary artery disease	0.000177	0.000447	CcSEcCtD
Dexmedetomidine—Dizziness—Niacin—coronary artery disease	0.000176	0.000445	CcSEcCtD
Dexmedetomidine—Dry mouth—Lisinopril—coronary artery disease	0.000176	0.000444	CcSEcCtD
Dexmedetomidine—Abdominal pain—Losartan—coronary artery disease	0.000175	0.000442	CcSEcCtD
Dexmedetomidine—Body temperature increased—Losartan—coronary artery disease	0.000175	0.000442	CcSEcCtD
Dexmedetomidine—Diarrhoea—Trandolapril—coronary artery disease	0.000174	0.00044	CcSEcCtD
Dexmedetomidine—Vomiting—Valsartan—coronary artery disease	0.000174	0.00044	CcSEcCtD
Dexmedetomidine—Confusional state—Lisinopril—coronary artery disease	0.000174	0.000439	CcSEcCtD
Dexmedetomidine—Diarrhoea—Enalapril—coronary artery disease	0.000174	0.000438	CcSEcCtD
Dexmedetomidine—Hypotension—Timolol—coronary artery disease	0.000174	0.000438	CcSEcCtD
Dexmedetomidine—Dizziness—Pravastatin—coronary artery disease	0.000174	0.000438	CcSEcCtD
Dexmedetomidine—Vomiting—Olmesartan—coronary artery disease	0.000173	0.000438	CcSEcCtD
Dexmedetomidine—Rash—Valsartan—coronary artery disease	0.000173	0.000436	CcSEcCtD
Dexmedetomidine—Dermatitis—Valsartan—coronary artery disease	0.000173	0.000436	CcSEcCtD
Dexmedetomidine—Nausea—Simvastatin—coronary artery disease	0.000172	0.000435	CcSEcCtD
Dexmedetomidine—Rash—Olmesartan—coronary artery disease	0.000172	0.000434	CcSEcCtD
Dexmedetomidine—Dermatitis—Olmesartan—coronary artery disease	0.000172	0.000434	CcSEcCtD
Dexmedetomidine—Headache—Valsartan—coronary artery disease	0.000172	0.000434	CcSEcCtD
Dexmedetomidine—Diarrhoea—Telmisartan—coronary artery disease	0.000171	0.000432	CcSEcCtD
Dexmedetomidine—Infection—Lisinopril—coronary artery disease	0.000171	0.000432	CcSEcCtD
Dexmedetomidine—Headache—Olmesartan—coronary artery disease	0.000171	0.000431	CcSEcCtD
Dexmedetomidine—Dyspnoea—Ramipril—coronary artery disease	0.000169	0.000428	CcSEcCtD
Dexmedetomidine—Vomiting—Niacin—coronary artery disease	0.000169	0.000428	CcSEcCtD
Dexmedetomidine—Somnolence—Ramipril—coronary artery disease	0.000169	0.000427	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Lisinopril—coronary artery disease	0.000169	0.000426	CcSEcCtD
Dexmedetomidine—Dizziness—Trandolapril—coronary artery disease	0.000168	0.000425	CcSEcCtD
Dexmedetomidine—Tachycardia—Lisinopril—coronary artery disease	0.000168	0.000425	CcSEcCtD
Dexmedetomidine—Rash—Niacin—coronary artery disease	0.000168	0.000424	CcSEcCtD
Dexmedetomidine—Dermatitis—Niacin—coronary artery disease	0.000168	0.000424	CcSEcCtD
Dexmedetomidine—Dizziness—Enalapril—coronary artery disease	0.000168	0.000424	CcSEcCtD
Dexmedetomidine—Headache—Niacin—coronary artery disease	0.000167	0.000422	CcSEcCtD
Dexmedetomidine—Vomiting—Pravastatin—coronary artery disease	0.000167	0.000421	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000167	0.000421	CcSEcCtD
Dexmedetomidine—Diarrhoea—Captopril—coronary artery disease	0.000167	0.00042	CcSEcCtD
Dexmedetomidine—Dyspnoea—Timolol—coronary artery disease	0.000166	0.000418	CcSEcCtD
Dexmedetomidine—Dizziness—Telmisartan—coronary artery disease	0.000166	0.000418	CcSEcCtD
Dexmedetomidine—Rash—Pravastatin—coronary artery disease	0.000165	0.000418	CcSEcCtD
Dexmedetomidine—Dermatitis—Pravastatin—coronary artery disease	0.000165	0.000417	CcSEcCtD
Dexmedetomidine—Somnolence—Timolol—coronary artery disease	0.000165	0.000417	CcSEcCtD
Dexmedetomidine—Headache—Pravastatin—coronary artery disease	0.000164	0.000415	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000164	0.000414	CcSEcCtD
Dexmedetomidine—Nausea—Valsartan—coronary artery disease	0.000163	0.000411	CcSEcCtD
Dexmedetomidine—Constipation—Ramipril—coronary artery disease	0.000163	0.00041	CcSEcCtD
Dexmedetomidine—Nausea—Olmesartan—coronary artery disease	0.000162	0.000409	CcSEcCtD
Dexmedetomidine—Vomiting—Trandolapril—coronary artery disease	0.000162	0.000409	CcSEcCtD
Dexmedetomidine—Diarrhoea—Perindopril—coronary artery disease	0.000162	0.000408	CcSEcCtD
Dexmedetomidine—Vomiting—Enalapril—coronary artery disease	0.000161	0.000407	CcSEcCtD
Dexmedetomidine—Hypotension—Lisinopril—coronary artery disease	0.000161	0.000407	CcSEcCtD
Dexmedetomidine—Dizziness—Captopril—coronary artery disease	0.000161	0.000406	CcSEcCtD
Dexmedetomidine—Rash—Trandolapril—coronary artery disease	0.000161	0.000406	CcSEcCtD
Dexmedetomidine—Dermatitis—Trandolapril—coronary artery disease	0.000161	0.000405	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Timolol—coronary artery disease	0.00016	0.000405	CcSEcCtD
Dexmedetomidine—Rash—Enalapril—coronary artery disease	0.00016	0.000404	CcSEcCtD
Dexmedetomidine—Dermatitis—Enalapril—coronary artery disease	0.00016	0.000404	CcSEcCtD
Dexmedetomidine—Headache—Trandolapril—coronary artery disease	0.00016	0.000403	CcSEcCtD
Dexmedetomidine—Vomiting—Telmisartan—coronary artery disease	0.000159	0.000402	CcSEcCtD
Dexmedetomidine—Headache—Enalapril—coronary artery disease	0.000159	0.000401	CcSEcCtD
Dexmedetomidine—Pain—Timolol—coronary artery disease	0.000159	0.000401	CcSEcCtD
Dexmedetomidine—Nausea—Niacin—coronary artery disease	0.000158	0.0004	CcSEcCtD
Dexmedetomidine—Rash—Telmisartan—coronary artery disease	0.000158	0.000398	CcSEcCtD
Dexmedetomidine—Dermatitis—Telmisartan—coronary artery disease	0.000158	0.000398	CcSEcCtD
Dexmedetomidine—Diarrhoea—Furosemide—coronary artery disease	0.000157	0.000397	CcSEcCtD
Dexmedetomidine—Headache—Telmisartan—coronary artery disease	0.000157	0.000396	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Ramipril—coronary artery disease	0.000157	0.000395	CcSEcCtD
Dexmedetomidine—Dizziness—Perindopril—coronary artery disease	0.000156	0.000395	CcSEcCtD
Dexmedetomidine—Nausea—Pravastatin—coronary artery disease	0.000156	0.000394	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000155	0.000392	CcSEcCtD
Dexmedetomidine—Vomiting—Captopril—coronary artery disease	0.000155	0.000391	CcSEcCtD
Dexmedetomidine—Dyspnoea—Lisinopril—coronary artery disease	0.000154	0.000388	CcSEcCtD
Dexmedetomidine—Rash—Captopril—coronary artery disease	0.000153	0.000387	CcSEcCtD
Dexmedetomidine—Dermatitis—Captopril—coronary artery disease	0.000153	0.000387	CcSEcCtD
Dexmedetomidine—Somnolence—Lisinopril—coronary artery disease	0.000153	0.000387	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Timolol—coronary artery disease	0.000153	0.000387	CcSEcCtD
Dexmedetomidine—Headache—Captopril—coronary artery disease	0.000152	0.000385	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Timolol—coronary artery disease	0.000152	0.000384	CcSEcCtD
Dexmedetomidine—Dizziness—Furosemide—coronary artery disease	0.000152	0.000384	CcSEcCtD
Dexmedetomidine—Diarrhoea—Losartan—coronary artery disease	0.000152	0.000383	CcSEcCtD
Dexmedetomidine—Nausea—Trandolapril—coronary artery disease	0.000151	0.000382	CcSEcCtD
Dexmedetomidine—Nausea—Enalapril—coronary artery disease	0.000151	0.000381	CcSEcCtD
Dexmedetomidine—Vomiting—Perindopril—coronary artery disease	0.00015	0.000379	CcSEcCtD
Dexmedetomidine—Body temperature increased—Ramipril—coronary artery disease	0.00015	0.000379	CcSEcCtD
Dexmedetomidine—Abdominal pain—Ramipril—coronary artery disease	0.00015	0.000379	CcSEcCtD
Dexmedetomidine—Rash—Perindopril—coronary artery disease	0.000149	0.000376	CcSEcCtD
Dexmedetomidine—Dermatitis—Perindopril—coronary artery disease	0.000149	0.000376	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000149	0.000376	CcSEcCtD
Dexmedetomidine—Nausea—Telmisartan—coronary artery disease	0.000149	0.000375	CcSEcCtD
Dexmedetomidine—Headache—Perindopril—coronary artery disease	0.000148	0.000374	CcSEcCtD
Dexmedetomidine—Pain—Lisinopril—coronary artery disease	0.000147	0.000372	CcSEcCtD
Dexmedetomidine—Constipation—Lisinopril—coronary artery disease	0.000147	0.000372	CcSEcCtD
Dexmedetomidine—Body temperature increased—Timolol—coronary artery disease	0.000147	0.000371	CcSEcCtD
Dexmedetomidine—Abdominal pain—Timolol—coronary artery disease	0.000147	0.000371	CcSEcCtD
Dexmedetomidine—Dizziness—Losartan—coronary artery disease	0.000147	0.00037	CcSEcCtD
Dexmedetomidine—Vomiting—Furosemide—coronary artery disease	0.000146	0.000369	CcSEcCtD
Dexmedetomidine—Rash—Furosemide—coronary artery disease	0.000145	0.000366	CcSEcCtD
Dexmedetomidine—Dermatitis—Furosemide—coronary artery disease	0.000145	0.000365	CcSEcCtD
Dexmedetomidine—Nausea—Captopril—coronary artery disease	0.000145	0.000365	CcSEcCtD
Dexmedetomidine—Headache—Furosemide—coronary artery disease	0.000144	0.000363	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Lisinopril—coronary artery disease	0.000142	0.000359	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000141	0.000356	CcSEcCtD
Dexmedetomidine—Vomiting—Losartan—coronary artery disease	0.000141	0.000356	CcSEcCtD
Dexmedetomidine—Nausea—Perindopril—coronary artery disease	0.00014	0.000354	CcSEcCtD
Dexmedetomidine—Rash—Losartan—coronary artery disease	0.00014	0.000353	CcSEcCtD
Dexmedetomidine—Dermatitis—Losartan—coronary artery disease	0.00014	0.000353	CcSEcCtD
Dexmedetomidine—Headache—Losartan—coronary artery disease	0.000139	0.000351	CcSEcCtD
Dexmedetomidine—Nausea—Furosemide—coronary artery disease	0.000136	0.000345	CcSEcCtD
Dexmedetomidine—Abdominal pain—Lisinopril—coronary artery disease	0.000136	0.000344	CcSEcCtD
Dexmedetomidine—Body temperature increased—Lisinopril—coronary artery disease	0.000136	0.000344	CcSEcCtD
Dexmedetomidine—Nausea—Losartan—coronary artery disease	0.000132	0.000332	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ramipril—coronary artery disease	0.00013	0.000328	CcSEcCtD
Dexmedetomidine—Diarrhoea—Timolol—coronary artery disease	0.000127	0.000321	CcSEcCtD
Dexmedetomidine—Dizziness—Ramipril—coronary artery disease	0.000126	0.000317	CcSEcCtD
Dexmedetomidine—Dizziness—Timolol—coronary artery disease	0.000123	0.00031	CcSEcCtD
Dexmedetomidine—Vomiting—Ramipril—coronary artery disease	0.000121	0.000305	CcSEcCtD
Dexmedetomidine—Rash—Ramipril—coronary artery disease	0.00012	0.000303	CcSEcCtD
Dexmedetomidine—Dermatitis—Ramipril—coronary artery disease	0.00012	0.000302	CcSEcCtD
Dexmedetomidine—Headache—Ramipril—coronary artery disease	0.000119	0.000301	CcSEcCtD
Dexmedetomidine—Vomiting—Timolol—coronary artery disease	0.000118	0.000298	CcSEcCtD
Dexmedetomidine—Diarrhoea—Lisinopril—coronary artery disease	0.000118	0.000298	CcSEcCtD
Dexmedetomidine—Rash—Timolol—coronary artery disease	0.000117	0.000296	CcSEcCtD
Dexmedetomidine—Dermatitis—Timolol—coronary artery disease	0.000117	0.000296	CcSEcCtD
Dexmedetomidine—Headache—Timolol—coronary artery disease	0.000116	0.000294	CcSEcCtD
Dexmedetomidine—Dizziness—Lisinopril—coronary artery disease	0.000114	0.000288	CcSEcCtD
Dexmedetomidine—Nausea—Ramipril—coronary artery disease	0.000113	0.000285	CcSEcCtD
Dexmedetomidine—Nausea—Timolol—coronary artery disease	0.00011	0.000279	CcSEcCtD
Dexmedetomidine—Vomiting—Lisinopril—coronary artery disease	0.00011	0.000277	CcSEcCtD
Dexmedetomidine—Rash—Lisinopril—coronary artery disease	0.000109	0.000274	CcSEcCtD
Dexmedetomidine—Dermatitis—Lisinopril—coronary artery disease	0.000109	0.000274	CcSEcCtD
Dexmedetomidine—Headache—Lisinopril—coronary artery disease	0.000108	0.000273	CcSEcCtD
Dexmedetomidine—Nausea—Lisinopril—coronary artery disease	0.000102	0.000259	CcSEcCtD
Dexmedetomidine—ADRA2A—Metabolism—APOA1—coronary artery disease	7.9e-06	3.21e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—coronary artery disease	7.88e-06	3.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	7.88e-06	3.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ESR1—coronary artery disease	7.86e-06	3.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CD36—coronary artery disease	7.84e-06	3.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PSMB5—coronary artery disease	7.77e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PSMA6—coronary artery disease	7.77e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FN1—coronary artery disease	7.76e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—F2—coronary artery disease	7.76e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	7.76e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPP2CA—coronary artery disease	7.75e-06	3.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	7.73e-06	3.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	7.73e-06	3.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—coronary artery disease	7.71e-06	3.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	7.7e-06	3.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GGT1—coronary artery disease	7.67e-06	3.12e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GOT1—coronary artery disease	7.67e-06	3.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	7.67e-06	3.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	7.67e-06	3.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	7.66e-06	3.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—F2—coronary artery disease	7.64e-06	3.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	7.64e-06	3.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	7.63e-06	3.1e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	7.61e-06	3.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CTGF—coronary artery disease	7.59e-06	3.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—POMC—coronary artery disease	7.57e-06	3.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	7.57e-06	3.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	7.55e-06	3.07e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GOT2—coronary artery disease	7.53e-06	3.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMGCR—coronary artery disease	7.53e-06	3.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	7.52e-06	3.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AGT—coronary artery disease	7.49e-06	3.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	7.48e-06	3.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—coronary artery disease	7.43e-06	3.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—KIT—coronary artery disease	7.43e-06	3.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	7.41e-06	3.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	7.4e-06	3.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	7.38e-06	3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—NOS3—coronary artery disease	7.37e-06	3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	7.35e-06	2.99e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOE—coronary artery disease	7.34e-06	2.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	7.31e-06	2.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	7.31e-06	2.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	7.28e-06	2.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOA1—coronary artery disease	7.26e-06	2.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	7.24e-06	2.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	7.19e-06	2.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—C3—coronary artery disease	7.18e-06	2.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	7.13e-06	2.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	7.1e-06	2.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—coronary artery disease	7.07e-06	2.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	7.07e-06	2.87e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AGT—coronary artery disease	7.06e-06	2.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	7.01e-06	2.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	6.96e-06	2.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARG—coronary artery disease	6.96e-06	2.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	6.96e-06	2.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	6.96e-06	2.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	6.92e-06	2.82e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PLCB1—coronary artery disease	6.92e-06	2.81e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—coronary artery disease	6.92e-06	2.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	6.92e-06	2.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	6.91e-06	2.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	6.89e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GSTP1—coronary artery disease	6.89e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—coronary artery disease	6.87e-06	2.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	6.85e-06	2.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOA1—coronary artery disease	6.84e-06	2.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	6.82e-06	2.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	6.82e-06	2.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	6.81e-06	2.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	6.8e-06	2.77e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—coronary artery disease	6.79e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—AKT1—coronary artery disease	6.79e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	6.79e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	6.79e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	6.77e-06	2.75e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—coronary artery disease	6.74e-06	2.74e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ABCA1—coronary artery disease	6.71e-06	2.73e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAT—coronary artery disease	6.7e-06	2.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	6.69e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	6.69e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	6.68e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	6.68e-06	2.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	6.66e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	6.61e-06	2.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	6.6e-06	2.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.55e-06	2.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	6.55e-06	2.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOB—coronary artery disease	6.51e-06	2.65e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	6.5e-06	2.65e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GGT1—coronary artery disease	6.5e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GOT1—coronary artery disease	6.5e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	6.48e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	6.47e-06	2.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	6.46e-06	2.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	6.41e-06	2.61e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARG—coronary artery disease	6.39e-06	2.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	6.38e-06	2.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	6.36e-06	2.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	6.35e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.33e-06	2.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—coronary artery disease	6.3e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—F2—coronary artery disease	6.3e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	6.3e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	6.29e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	6.28e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	6.26e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—coronary artery disease	6.26e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	6.25e-06	2.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	6.23e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—LPL—coronary artery disease	6.21e-06	2.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	6.21e-06	2.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	6.17e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	6.16e-06	2.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	6.15e-06	2.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	6.07e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—coronary artery disease	6.06e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	6.04e-06	2.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	6.03e-06	2.45e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARG—coronary artery disease	6.03e-06	2.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	5.99e-06	2.44e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—NOS3—coronary artery disease	5.99e-06	2.44e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—coronary artery disease	5.94e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CD36—coronary artery disease	5.9e-06	2.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	5.9e-06	2.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	5.87e-06	2.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	5.86e-06	2.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	5.85e-06	2.38e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GSTP1—coronary artery disease	5.84e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.83e-06	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	5.79e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	5.78e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	5.78e-06	2.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—coronary artery disease	5.75e-06	2.34e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—coronary artery disease	5.75e-06	2.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	5.74e-06	2.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	5.74e-06	2.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	5.69e-06	2.31e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAT—coronary artery disease	5.68e-06	2.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	5.65e-06	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	5.62e-06	2.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	5.6e-06	2.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	5.6e-06	2.28e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.59e-06	2.28e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	5.57e-06	2.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	5.52e-06	2.25e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOB—coronary artery disease	5.51e-06	2.24e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—NOS3—coronary artery disease	5.5e-06	2.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	5.5e-06	2.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—coronary artery disease	5.48e-06	2.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	5.47e-06	2.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	5.45e-06	2.22e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—coronary artery disease	5.42e-06	2.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	5.38e-06	2.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GSTM1—coronary artery disease	5.36e-06	2.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AGT—coronary artery disease	5.32e-06	2.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	5.29e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	5.28e-06	2.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	5.27e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—LPL—coronary artery disease	5.26e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.25e-06	2.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	5.24e-06	2.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	5.23e-06	2.13e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—coronary artery disease	5.21e-06	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	5.2e-06	2.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	5.2e-06	2.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—NOS3—coronary artery disease	5.18e-06	2.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	5.15e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOA1—coronary artery disease	5.15e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—coronary artery disease	5.14e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	5.13e-06	2.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	5.12e-06	2.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	5.09e-06	2.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	5.08e-06	2.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—coronary artery disease	5.03e-06	2.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	5.01e-06	2.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	5.01e-06	2.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CD36—coronary artery disease	5e-06	2.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	4.95e-06	2.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	4.94e-06	2.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	4.87e-06	1.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	4.87e-06	1.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	4.83e-06	1.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	4.8e-06	1.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.77e-06	1.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	4.75e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—coronary artery disease	4.74e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	4.74e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—coronary artery disease	4.74e-06	1.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	4.72e-06	1.92e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARG—coronary artery disease	4.54e-06	1.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AGT—coronary artery disease	4.5e-06	1.83e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—coronary artery disease	4.47e-06	1.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	4.44e-06	1.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	4.44e-06	1.81e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—coronary artery disease	4.41e-06	1.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	4.37e-06	1.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	4.36e-06	1.77e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOA1—coronary artery disease	4.36e-06	1.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	4.29e-06	1.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	4.28e-06	1.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	4.25e-06	1.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	4.22e-06	1.72e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.18e-06	1.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	4.15e-06	1.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	4.14e-06	1.68e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	4.11e-06	1.67e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—coronary artery disease	4.08e-06	1.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	4.08e-06	1.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	4.02e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	4.01e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	4e-06	1.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	3.93e-06	1.6e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NOS3—coronary artery disease	3.9e-06	1.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	3.9e-06	1.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARG—coronary artery disease	3.84e-06	1.56e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—coronary artery disease	3.79e-06	1.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	3.71e-06	1.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	3.64e-06	1.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	3.61e-06	1.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.57e-06	1.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	3.47e-06	1.41e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—coronary artery disease	3.46e-06	1.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	3.41e-06	1.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AKT1—coronary artery disease	3.39e-06	1.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	3.37e-06	1.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	3.36e-06	1.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	3.31e-06	1.35e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NOS3—coronary artery disease	3.31e-06	1.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	3.29e-06	1.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	3.25e-06	1.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3CA—coronary artery disease	3.09e-06	1.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	3.07e-06	1.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	3.03e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.02e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	3.02e-06	1.23e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3CA—coronary artery disease	2.92e-06	1.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	2.83e-06	1.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	2.82e-06	1.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	2.79e-06	1.13e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AKT1—coronary artery disease	2.75e-06	1.12e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AKT1—coronary artery disease	2.53e-06	1.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	2.49e-06	1.01e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AKT1—coronary artery disease	2.38e-06	9.69e-06	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	2.3e-06	9.36e-06	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.2e-06	8.93e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.86e-06	7.56e-06	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.79e-06	7.29e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKT1—coronary artery disease	1.52e-06	6.18e-06	CbGpPWpGaD
